These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 34909278)

  • 1. EpiCurator: an immunoinformatic workflow to predict and prioritize SARS-CoV-2 epitopes.
    Ferreira CS; Martins YC; Souza RC; Vasconcelos ATR
    PeerJ; 2021; 9():e12548. PubMed ID: 34909278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches.
    Safavi A; Kefayat A; Mahdevar E; Abiri A; Ghahremani F
    Vaccine; 2020 Nov; 38(48):7612-7628. PubMed ID: 33082015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A conserved subunit vaccine designed against SARS-CoV-2 variants showed evidence in neutralizing the virus.
    Kibria KMK; Faruque MO; Islam MSB; Ullah H; Mahmud S; Miah M; Saleh AA
    Appl Microbiol Biotechnol; 2022 Jun; 106(11):4091-4114. PubMed ID: 35612630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immuno-Informatics Quest against COVID-19/SARS-COV-2: Determining Putative T-Cell Epitopes for Vaccine Prediction.
    Akhtar N; Joshi A; Singh B; Kaushik V
    Infect Disord Drug Targets; 2021; 21(4):541-552. PubMed ID: 32957905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A vaccine built from potential immunogenic pieces derived from the SARS-CoV-2 spike glycoprotein: A computational approximation.
    Marchan J
    J Immunol Methods; 2022 Mar; 502():113216. PubMed ID: 35007561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-epitope vaccine against SARS-CoV-2 applying immunoinformatics and molecular dynamics simulation approaches.
    Jyotisha ; Singh S; Qureshi IA
    J Biomol Struct Dyn; 2022 Apr; 40(7):2917-2933. PubMed ID: 33164664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence-based prediction of SARS-CoV-2 vaccine targets using a mass spectrometry-based bioinformatics predictor identifies immunogenic T cell epitopes.
    Poran A; Harjanto D; Malloy M; Arieta CM; Rothenberg DA; Lenkala D; van Buuren MM; Addona TA; Rooney MS; Srinivasan L; Gaynor RB
    Genome Med; 2020 Aug; 12(1):70. PubMed ID: 32791978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An immunoinformatics study on the spike protein of SARS-CoV-2 revealing potential epitopes as vaccine candidates.
    Ashik AI; Hasan M; Tasnim AT; Chowdhury MB; Hossain T; Ahmed S
    Heliyon; 2020 Sep; 6(9):e04865. PubMed ID: 32923731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reverse vaccinology assisted designing of multiepitope-based subunit vaccine against SARS-CoV-2.
    Tahir Ul Qamar M; Shahid F; Aslam S; Ashfaq UA; Aslam S; Fatima I; Fareed MM; Zohaib A; Chen LL
    Infect Dis Poverty; 2020 Sep; 9(1):132. PubMed ID: 32938504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoinformatics prediction of overlapping CD8
    Fatoba AJ; Maharaj L; Adeleke VT; Okpeku M; Adeniyi AA; Adeleke MA
    Vaccine; 2021 Feb; 39(7):1111-1121. PubMed ID: 33478794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 coronavirus vaccine T cell epitope prediction analysis based on distributions of HLA class I loci (HLA-A, -B, -C) across global populations.
    Cun Y; Li C; Shi L; Sun M; Dai S; Sun L; Shi L; Yao Y
    Hum Vaccin Immunother; 2021 Apr; 17(4):1097-1108. PubMed ID: 33175614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Immunological Profiles of SARS-CoV-2 Variants in the COVID-19 Pandemic Trends: An Immunoinformatics Approach.
    Mallavarpu Ambrose J; Priya Veeraraghavan V; Kullappan M; Chellapandiyan P; Krishna Mohan S; Manivel VA
    Antibiotics (Basel); 2021 May; 10(5):. PubMed ID: 34066389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational perspectives revealed prospective vaccine candidates from five structural proteins of novel SARS corona virus 2019 (SARS-CoV-2).
    Anand R; Biswal S; Bhatt R; Tiwary BN
    PeerJ; 2020; 8():e9855. PubMed ID: 33062414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deciphering the immunogenic T-cell epitopes from spike protein of SARS-CoV-2 concerning the diverse population of India.
    Devi SS; Kardam V; Dubey KD; Dwivedi M
    J Biomol Struct Dyn; 2023 Apr; 41(7):2713-2732. PubMed ID: 35132938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designing a Multi-epitope Vaccine against the SARS-CoV-2 Variant based on an Immunoinformatics Approach.
    Farhani I; Yamchi A; Madanchi H; Khazaei V; Behrouzikhah M; Abbasi H; Salehi M; Moradi N; Sanami S
    Curr Comput Aided Drug Des; 2024; 20(3):274-290. PubMed ID: 37309762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study.
    Yang Z; Bogdan P; Nazarian S
    Sci Rep; 2021 Feb; 11(1):3238. PubMed ID: 33547334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2.
    Chen HZ; Tang LL; Yu XL; Zhou J; Chang YF; Wu X
    Infect Dis Poverty; 2020 Jul; 9(1):88. PubMed ID: 32741372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epitope identification of SARS-CoV-2 structural proteins using in silico approaches to obtain a conserved rational immunogenic peptide.
    Araújo LP; Dias MEC; Scodeler GC; Santos AS; Soares LM; Corsetti PP; Padovan ACB; Silveira NJF; de Almeida LA
    Immunoinformatics (Amst); 2022 Sep; 7():100015. PubMed ID: 35721890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of multi-epitope vaccine candidate against SARS-CoV-2: a
    Abraham Peele K; Srihansa T; Krupanidhi S; Ayyagari VS; Venkateswarulu TC
    J Biomol Struct Dyn; 2021 Jul; 39(10):3793-3801. PubMed ID: 32419646
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.